VERICEL CORPORATION Deferred Rent Credit, Current
VERICEL CORPORATION (VCEL) had Deferred Rent Credit, Current of $566.00 thousand as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRentCreditCurrent · last filed 2019-02-26
- 2018-12-31: Deferred Rent Credit, Current $566.00K.
- 2017-12-31: Deferred Rent Credit, Current $420.00K.
- 2016-12-31: Deferred Rent Credit, Current $3.00K.
- 2016-09-30: Deferred Rent Credit, Current $232.00K.
| Period end | Deferred Rent Credit, Current |
|---|---|
| 2018-12-31 | $566.00K 10-K · filed 2019-02-26 |
| 2017-12-31 | $420.00K 10-K · filed 2019-02-26 |
| 2016-12-31 | $3.00K 10-K · filed 2018-03-05 |
| 2016-09-30 | $232.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $460.00K 10-Q · filed 2016-08-08 |
| 2015-12-31 | $118.00K 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |